AVR

1.29%

$18.31 anteris technologies ltd

Have you found any clinical trials for competitors products?...

First 39 Last

Share
Profile

Follow
lexcorp

7,952 Posts.

499

12/04/19

10:23

Post #: 38111029
Share

Originally posted by jag142 ↑

Appologoes if I tread on any toes in advance............

The uptake of the product has been much slower than many of us wanted/ anticipated/ expected.

At a risk of repeating myself,

The product is not a new brand of washing up detergent, type of nail gun, brand of pet food or oil for your car......(feel free to insert any other consumable here - but I am sure that you get the idea).

more specific, it is not a different brand of bandage, medical instrument or even medication.

It is a product that can not be easily re[placed if not functioning, and has dire consequences associated with failure, with minimal (and I mean that....minimal as a stretch) evidence that will likely satisfy the clinicians to quickly use it. Appologies to any clinicaians out there if I am off the mark.

we have 10 years of clinical experience - no real human clinical 'trials' that I am aware of - all we have is a large international case series (it was 30 patients 5 years ago, however in the thousands now) . And it is the high level clinical trials that will generally provide the sufficient level of evidence that will support uptake by the specialists in large numbers.....that is currently available. Yes we have case reports and presentations adn even U Tube videos...but no controlled randomised trial.........there was one started but it was stopped.

The q on q increase in reciepts (sales) mean that the use of the product(s) is increasing (yay!!!!) however, for the rapid acceptance that so many of us hoped for, it is not likely to happen.

The product is gaining traction and hopefully will continue (thats why we are all still here) but it is an industry with traditional approaches to trying new ideas (products) adn that is unlikely to change.

The train is rolling and it will gather speed - it may just still take a while for all to want to jump on.

Just my 2c (or 20c post consolidation)

bring on the 50c/$5.00 BBQ.

Expand

Have you found any clinical trials for competitors products?

Also remember hospitals just don't start using a product like this because their in contracts with others

AHZ Price at posting: 6.8¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce's R327 found effective against E.coli during clinical trial

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Microcap Wrap: 5 explorers with news out today

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

There are more pages in this discussion • 14 more messages in this thread...

First 39 Last

Add AVR (ASX) to my watchlist

(20min delay)
Last $18.31		Change -0.240(1.29%)		Mkt cap ! $351.9M

Open	High	Low	Value	Volume
$18.80	$19.15	$18.20	$159.7K	8.611K

Buyers (Bids)

No.	Vol.	Price($)
1	73	$18.31

Sellers (Offers)

Price($)	Vol.	No.
$18.33	90	1

View Market Depth

No.	Vol.	Price($)
1	150	18.100
1	100	18.050
1	250	18.010
2	2010	18.000
1	55	17.910

Price($)	Vol.	No.
19.000	500	1
20.000	2950	4
20.120	420	1
20.200	309	1
20.400	678	1

Last trade - 16.10pm 28/06/2024 (20 minute delay)

AVR (ASX) Chart

Have you found any clinical trials for competitors products?...

Recce's R327 found effective against E.coli during clinical trial

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Microcap Wrap: 5 explorers with news out today

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Ava Risk Group expands US presence with A$0.7M Substation Deal

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Have you found any clinical trials for competitors products?...

Top Stories

Recce's R327 found effective against E.coli during clinical trial

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Microcap Wrap: 5 explorers with news out today

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Ava Risk Group expands US presence with A$0.7M Substation Deal

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News